Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 4/20 | 0.40 |
| ▸ | MGAM | O43451 | 2/20 | 0.40 |
| ▸ | SI | P14410 | 2/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | GSK3B | P49841 | 2/20 | 0.37 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.37 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.37 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.37 |
| ▸ | GSK3A | P49840 | 1/20 | 0.37 |
| ▸ | CTSV | O60911 | 1/20 | 0.37 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7733259 | 0.82 | MEN1 (0.44) | MEN1KMT2AMAPTKDM4EALDH1A1 | |
| SCHEMBL6152024 | 0.72 | KMT2A (0.40) | KIF11MEN1KMT2APOLBNPC1 | |
| SCHEMBL23272971 | 0.68 | ACHE (0.41) | CYP1A2ALDH1A1ALOX15TDP1 | |
| SCHEMBL2595994 | 0.68 | KIF11 (0.57) | KIF11MEN1KMT2APOLBNPC1 | |
| SCHEMBL24633215 | 0.68 | ELANE (0.45) | MEN1KMT2APOLBMAPTHPGD | |
| SCHEMBL2787277 | 0.67 | KIF11 (0.41) | KIF11MEN1KMT2APOLBNPC1 | |
| SCHEMBL27951196 | 0.66 | PARP14 (0.60) | KIF11MEN1KMT2APOLBNPC1 | |
| SCHEMBL14028585 | 0.66 | SERPINE1 (0.40) | MEN1KMT2AKDM4EGAACYP1A2 | |
| SCHEMBL29563317 | 0.65 | KIF11 (0.77) | KIF11MEN1KMT2APOLBNPC1 | |
| SCHEMBL607346 | 0.65 | KIF11 (1.00) | KIF11MEN1KMT2APOLBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1543045-A1 | OLEFIN POLYMERIZATION PROCESS | Equistar Chemicals, LP (US) | 2005-06-22 | — | — | EP | disclosed |
| US-6765074-B2 | SUPPORTED INDENOINDOLYL CATALYST SYSTEM AND AN ORGANOBORON OR ORGANOALUMINUM-TREATED SOLID | EQUISTAR CHEMICALS, LP | 2004-07-20 | — | — | US | disclosed |
| EP-1412399-A1 | SUPPORTED OLEFIN POLYMERIZATION CATALYSTS | Equistar Chemicals, LP (US) | 2004-04-28 | — | — | EP | disclosed |
| WO-2004029102-A1 | OLEFIN POLYMERIZATION PROCESS | EQUISTAR CHEMICALS, LP (US) | 2004-04-08 | — | — | WO | disclosed |
| US-20040063876-A1 | Olefin polymerization process | EQUISTAR CHEMICALS, LP | 2004-04-01 | — | — | US | disclosed |
| US-6583242-B2 | Alumoxane, organometallic complex containing an indenoindolyl ligand, an activator; copolymerizing ethylene with a C3-C10 alpha-olefin | EQUISTAR CHEMICALS, LP | 2003-06-24 | — | — | US | disclosed |
| US-20030050413-A1 | Supported olefin polymerization catalysts | EQUISTAR CHEMICALS, LP | 2003-03-13 | — | — | US | disclosed |
| WO-2003011921-A1 | SUPPORTED OLEFIN POLYMERIZATION CATALYSTS | EQUISTAR CHEMICALS, LP (US) | 2003-02-13 | — | — | WO | disclosed |
| US-6376629-B2 | ORGANOMETALLIC COMPOUND | EQUISTAR CHEMICALS, LP | 2002-04-23 | — | — | US | disclosed |
| US-20010007848-A1 | Single-site catalysts for olefin polymerization | EQUISTAR CHEMICALS, L.P. | 2001-07-12 | — | — | US | disclosed |
| US-6232260-B1 | ORGANOMETALLIC COMPLEX COMPRISES A GROUP 3 TO 10 TRANSITION OR LANTHANIDE METAL, M, AND AT LEAST ONE INDENOINDOLYL LIGAND THAT IS .PI.-BONDED TO M. | EQUISTAR CHEMICALS, L.P. | 2001-05-15 | — | — | US | disclosed |
| WO-2001027125-A1 | SINGLE-SITE CATALYSTS FOR OLEFIN POLYMERIZATION | EQUISTAR CHEMICALS, L.P. (US) | 2001-04-19 | — | — | WO | disclosed |